Literature DB >> 1586078

A controlled clinical comparison of four different surfactant preparations in surfactant-deficient preterm lambs.

J J Cummings1, B A Holm, M L Hudak, B B Hudak, W H Ferguson, E A Egan.   

Abstract

Four pulmonary surfactant preparations (natural sheep surfactant, Exosurf, Infasurf, and Survanta) were compared with no treatment in 29 newborn lambs at 126 +/- 1 days gestation. Fetuses were delivered by Cesarean section under general anesthesia and treated with either the manufacturer's recommended dose of a commercial surfactant, 100 mg phospholipid/kg of natural sheep surfactant, or no surfactant (control group). Lambs were mechanically ventilated with 100% oxygen until moribund from respiratory failure or until killed at 24 h after delivery. Lambs surviving to 12 h received surfactant retreatment (of the same type) if hypoxemic. All lambs were surfactant deficient at birth, having less than 0.1 mg/ml of phospholipid measured in the lung liquid. All control lambs developed early respiratory failure and died within 8 h after delivery. Survival was significantly prolonged by natural surfactant (p less than 0.02), Infasurf (p less than 0.0001), and Survanta (p less than 0.02). Natural surfactant, Infasurf, and Survanta significantly improved arterial oxygenation and ventilatory compliance compared with no treatment. These effects lasted as long as 24 h in lambs given Infasurf, but no more than 6 h in lambs given natural surfactant or Survanta. After death, static pressure-volume lung mechanics were significantly better for lambs given natural sheep surfactant, Infasurf, or Survanta. Lambs given Exosurf were no different than control lambs in any variable measured. Thus, in 126-day gestation surfactant-deficient newborn lambs, natural sheep surfactant, Infasurf, and Survanta, but not Exosurf, Improve oxygenation, lung mechanics, and survival.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586078     DOI: 10.1164/ajrccm/145.5.999

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  24 in total

Review 1.  Calfactant: a review of its use in neonatal respiratory distress syndrome.

Authors:  S V Onrust; M Dooley; K L Goa
Journal:  Paediatr Drugs       Date:  1999 Jul-Sep       Impact factor: 3.022

2.  Synthetic and natural surfactant differentially modulate inflammation after meconium aspiration.

Authors:  Anne Hilgendorff; Daniel Rawer; Martin Doerner; Erol Tutdibi; Michael Ebsen; Reinhold Schmidt; Andreas Guenther; Ludwig Gortner; Irwin Reiss
Journal:  Intensive Care Med       Date:  2003-09-03       Impact factor: 17.440

Review 3.  Lung surfactants for neonatal respiratory distress syndrome: animal-derived or synthetic agents?

Authors:  Gautham K Suresh; Roger F Soll
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Surfactant therapy for meconium aspiration syndrome: current status.

Authors:  Peter A Dargaville; John F Mills
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Lavage administration of dilute surfactant in a piglet model of meconium aspiration.

Authors:  Joan Meister; Venkataraman Balaraman; Malia Ramirez; Catherine F T Uyehara; Jeffrey Killeen; Tercia Ku; Donald Person; David Easa
Journal:  Lung       Date:  2004       Impact factor: 2.584

6.  A risk-benefit assessment of natural and synthetic exogenous surfactants in the management of neonatal respiratory distress syndrome.

Authors:  H Walti; M Monset-Couchard
Journal:  Drug Saf       Date:  1998-05       Impact factor: 5.606

Review 7.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 8.  Making the most out of the least: new insights into congenital diaphragmatic hernia.

Authors:  H L Karamanoukian; S J O'Toole; B A Holm; P L Glick
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

9.  Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid.

Authors:  T A Merritt; J D Amirkhanian; H Helbock; B Halliwell; C E Cross
Journal:  Biochem J       Date:  1993-10-01       Impact factor: 3.857

10.  Multicentre randomised trial comparing high and low dose surfactant regimens for the treatment of respiratory distress syndrome (the Curosurf 4 trial).

Authors:  H L Halliday; W O Tarnow-Mordi; J D Corcoran; C C Patterson
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.